GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
P3 Health Partners
Who Owns P3 Health Partners?
Understanding a company's ownership is key to grasping its strategy and market influence. P3 Health Partners Inc., a physician-led population health management firm founded in 2015, aims to improve health outcomes and lower costs, especially for Medicare Advantage patients.
The company went public in December 2021 via a SPAC merger, valuing the combined entity at approximately $2.3 billion and listing on Nasdaq under 'PIII'. As of July 2025, its market cap hovers between $52.26 million and $59.9 million USD.
The ownership of P3 Health Partners is a mix of its founders, early investors, institutional shareholders, and the public. This structure influences its governance and strategic direction, including its approach to value-based care and chronic disease management, as detailed in analyses like the P3 Health Partners BCG Matrix.
Who Founded P3 Health Partners?
P3 Health Partners was established in 2015 by physicians, with Sherif Abdou, M.D., and Amir Bacchus, M.D., as its co-founders. Their vision centered on enhancing patient care through a physician-led, patient-focused, and population health-driven model. While the precise initial equity distribution among the founders remains undisclosed, their commitment to value-based care was fundamental to the company's early operational framework.
Founding Vision
The company was founded by physicians aiming to transform healthcare delivery. Their core philosophy emphasized a patient-centered and physician-led approach to population health.
Co-Founders
Sherif Abdou, M.D., and Amir Bacchus, M.D., are recognized as the co-founders of P3 Health Partners. Their shared passion for improving patient outcomes guided the company's inception.
Early Investment
Chicago Pacific Founders provided crucial early and growth capital to P3 Health Partners. This investment was instrumental in scaling operations and expanding the provider network.
Investor Role
The backing from Chicago Pacific Founders, a venture capital firm, was vital for P3 Health Partners' development. Their support facilitated operational expansion and network growth.
Operational Philosophy
The company's early operational philosophy was deeply rooted in empowering providers and prioritizing holistic patient wellness. This approach aimed to differentiate from traditional volume-based healthcare models.
Ownership Details
Specific details regarding initial equity splits or shareholding percentages for the founders are not publicly available. Information on early agreements like vesting schedules is also not extensively disclosed.
In its formative stages, P3 Health Partners secured essential early and growth capital from Chicago Pacific Founders, a significant investor that played a pivotal role in the company's trajectory before its public market debut. This venture capital firm's financial support was critical for scaling P3's operations and broadening its network of primary care providers. While public records do not extensively detail early agreements such as vesting schedules or buy-sell clauses, the involvement of a private equity firm like Chicago Pacific Founders typically involves structured investment terms designed to foster growth and align stakeholder interests. There is no publicly accessible information suggesting any initial ownership disputes or buyouts among the founding team. The founding team's core vision of empowering healthcare providers and focusing on comprehensive patient well-being was deeply integrated into the company's operational model from its inception, attracting both partners and patients who sought an alternative to conventional volume-based healthcare systems. Understanding the Target Market of P3 Health Partners can provide further context on the company's strategic direction.
Founders and Early Stakeholders
The initial ownership structure of P3 Health Partners was shaped by its physician founders and early investors. Key figures like Sherif Abdou, M.D., and Amir Bacchus, M.D., laid the groundwork, supported by crucial capital from Chicago Pacific Founders.
- Founders: Sherif Abdou, M.D., and Amir Bacchus, M.D.
- Key Early Investor: Chicago Pacific Founders
- Founding Principle: Physician-led, patient-centered, population health focus
- Early Capital Infusion: Provided by Chicago Pacific Founders for scaling operations
Complete P3 Health Partners Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has P3 Health Partners’s Ownership Changed Over Time?
The ownership structure of P3 Health Partners saw a significant shift when it became a publicly traded entity on December 6, 2021, following a business combination with Foresight Acquisition Corp., a SPAC. This move provided P3 with access to public capital markets to fuel its expansion. At the time of this merger, P3's existing members were anticipated to hold approximately 75% of the combined company's equity.
| Stakeholder Type | Percentage of Ownership (as of March 30, 2025) | Number of Shares (as of March 30, 2025) |
|---|---|---|
| VC/PE Firms | 54% | 1,763,155 |
| General Public | 31.7% | 1,036,701 |
| Institutions | 4.98% | 162,869 |
| Hedge Funds | 5.54% | 180,906 |
As of July and August 2025, P3 Health Partners is recognized as a micro-cap company, with its market capitalization reported between $41.69 million and $59.9 million USD. The company's 2024 Form 10-K, filed on March 28, 2025, details its financial performance and strategic direction. The transition to a public company has increased reporting obligations and market scrutiny, influencing P3's focus on financial stability and growth in 2025, aligning with strategies discussed in the Marketing Strategy of P3 Health Partners.
Key P3 Health Partners Stakeholders
P3 Health Partners' ownership is distributed among various groups, including institutional investors, venture capital and private equity firms, and the general public. Understanding these P3 Health Partners stakeholders is crucial for assessing the company's direction and stability.
- Institutional investors held approximately 7.75% of P3 Health Partners' stock as of July 28, 2025.
- Fintel identified 10 institutional owners and shareholders as of July 28, 2025.
- Notable institutional holders include Welch Capital Partners LLC/NY and Alyeska Investment Group L.P.
- VC/PE Firms represented a significant portion of ownership, holding 54% of shares as of March 30, 2025.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on P3 Health Partners’s Board?
The Board of Directors at P3 Health Partners Inc. is instrumental in guiding the company's strategic direction and governance. This board comprises individuals with diverse expertise, including founders and independent directors with substantial experience in healthcare and finance. As of July 2025, key members include Dr. Aric Coffman (CEO, President & Director) and Dr. Amir Bacchus (Co-Founder), alongside independent directors such as Mark Thierer (Chairman of the Board).
| Director Name | Role | Affiliation |
|---|---|---|
| Dr. Aric Coffman | CEO, President & Director | Internal |
| Dr. Amir Bacchus | Co-Founder | Founder |
| Mark Thierer | Independent Chairman of the Board | Independent |
| Mary Tolan | Independent Director | Independent |
| Gregory Wasson | Independent Director | Independent |
| Jeffrey Park | Independent Director | Independent |
| Lawrence Leisure | Independent Director | Independent |
| Gregory Kazarian | Director | Internal |
| Thomas Price | Independent Director | Independent |
P3 Health Partners Inc. operates with a dual-class share structure, influencing voting power among its shareholders. Both Class A and Class V common stock holders are granted one vote per share on most matters, voting as a single class. As of March 13, 2025, the company had 163,159,548 shares of Class A common stock and 195,956,984 shares of Class V common stock outstanding. This structure can lead to concentrated voting power, though specific details regarding disproportionate control are not publicly detailed. Recent shareholder meetings, such as the Special Meeting on March 31, 2025, and the Annual Meeting on June 4, 2025, demonstrate active shareholder participation in key decisions, including the approval of a reverse stock split and the election of directors, reflecting strong support for the company's strategic direction and Revenue Streams & Business Model of P3 Health Partners.
Board and Shareholder Dynamics
The composition of the P3 Health Partners board and recent shareholder actions highlight active governance and strategic alignment.
- Dr. Sherif Abdou resigned from the board on July 2, 2025.
- Dr. Aric Coffman was appointed to fill the board vacancy.
- Shareholders approved a reverse stock split in March 2025.
- Executive compensation and auditor ratification received strong shareholder approval in June 2025.
P3 Health Partners Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped P3 Health Partners’s Ownership Landscape?
Over the past few years, P3 Health Partners has undergone a significant transformation in its ownership structure, notably becoming a publicly traded entity in December 2021 via a SPAC merger. This strategic move was intended to fuel growth, though the company's market capitalization has experienced a notable decline since its public debut.
| Metric | Value | Date |
|---|---|---|
| Market Cap Change (1 Year) | -34.52% | July 25, 2025 |
| Market Cap Change (Since IPO) | -86.28% | April 6, 2021 |
| Private Placement Raised | $39.8 million (net) | May 2024 |
| Florida Assets Sale | ~$15 million | 2024 |
| Term Loan Facility Outstanding | $65 million | December 31, 2024 |
| At-Risk Members (2023) | 108,900 | 2023 |
| At-Risk Members (2024) | 123,800 | 2024 |
| Primary Care Physicians (End of 2024) | ~3,100 | End of 2024 |
The company has actively managed its capital through various transactions, including a private placement in May 2024 that raised $39.8 million. P3 Health Partners also entered into financing agreements with VBC Growth SPV entities, issuing promissory notes. Furthermore, the sale of its Florida Assets for approximately $15 million contributed to its financial activities. As of December 31, 2024, the company had $65 million outstanding under its Term Loan Facility with CRG Servicing, LLC. Anticipating continued operating losses and negative cash flows, P3 Health Partners plans to seek additional capital through debt and equity financing, alongside potential asset sales, to support its operations throughout 2025.
Capital Infusion and Asset Management
P3 Health Partners has recently secured capital through a private placement and has divested certain assets to manage its financial position. These actions are part of a broader strategy to address ongoing financial needs.
Future Funding Strategy
The company anticipates a need for further funding in 2025 due to operating losses. Plans include exploring additional debt and equity financing, as well as potential asset sales to ensure financial sustainability.
Leadership and Board Changes
Dr. Sherif Abdou, a co-founder, has resigned from the Board of Directors as of July 2, 2025. CEO Dr. Aric Coffman has been appointed to the board to fill the vacancy, reflecting shifts in the P3 Health Partners management team ownership.
Membership and Network Expansion
The company is focused on growing its Medicare Advantage membership and primary care physician network. This expansion aims to leverage existing infrastructure and increase patient share within its network, contributing to its strategic growth objectives.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of P3 Health Partners Company?
- What is Competitive Landscape of P3 Health Partners Company?
- What is Growth Strategy and Future Prospects of P3 Health Partners Company?
- How Does P3 Health Partners Company Work?
- What is Sales and Marketing Strategy of P3 Health Partners Company?
- What are Mission Vision & Core Values of P3 Health Partners Company?
- What is Customer Demographics and Target Market of P3 Health Partners Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.